Skip to content
Catalyst

PapersPMID:30151373

Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study.

BioMed research international2018The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidenceno difference foundGlycated haemoglobin (HbA1c)
  2. Finding, moderate evidenceno difference foundFasting blood glucose
Study, every finding
RCT · 8 weeks
Dose studied, every finding
coenzyme Q10 200 mg/day for 8 weeks
Population, every finding
adults with impaired glucose tolerance (prediabetes)

No finding here moved its endpoint.

Study record

Design
randomised controlled trial
Species
human
Population
adults aged 20-65 years with impaired glucose tolerance (prediabetes)
Participants
80
Comparator
placebo
Duration
56 days
Endpoints measured
8